Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 25, 2009
Upgrade follows the Moody's actions of March 12, when it raised Company's outlook to stable from negative
-
Mar 19, 2009
iCross™ designed to improve the deliverability of Company's market-leading intravascular ultrasound (IVUS) technology
-
Mar 12, 2009
Rating agency notes that Company has been able to retain market share in the DES arena while rebuilding its CRM presence with new product launches
-
Mar 10, 2009
A live webcast of the March 17 conference session will be available.
-
Mar 4, 2009
Legislation to evaluate the current state of chronic pain care will now move to consideration by the full House
-
Mar 3, 2009
Japanese patients now have access to second-generation drug-eluting stent
-
Mar 2, 2009
Joel Fleishman to retire from Board
-
Feb 26, 2009
Adjustments reflected in the Company's Form 10-K to be filed tomorrow
-
Feb 18, 2009
Data show comparable safety for complex patients treated with TAXUS® Express2™ Stents and bypass surgery
-
Feb 5, 2009
Journal of American College of Cardiology publishes positive ATLAS clinical data
-
Feb 3, 2009
PLATINUM clinical program to evaluate PROMUS™ Element™ Platinum Chromium Stent
-
Jan 28, 2009
Q4 adjusted results in line with expectations; Company well positioned for 2009 and beyond
-
Jan 28, 2009
Product is Japan's first second-generation drug-eluting stent
-
Jan 27, 2009
Agreement stops all litigation in interventional cardiology and endovascular repair
-
Jan 20, 2009
Provides Company the opportunity to supply therapies for VA patients at risk of sudden cardiac death and bradycardia arrhythmias
-
Jan 15, 2009
Court found patent to be invalid as obvious over the prior art; Company considering its options for challenging the decision
-
Jan 13, 2009
Company will webcast its January 29 conference call
-
Jan 7, 2009
A live webcast of the January 14 presentation will be available
-
Jan 6, 2009
Acquisition demonstrates Company's commitment to innovation in drug-eluting stent technology
-
Dec 18, 2008
First patient enrolled in Carotid WALLSTENT® Endoprosthesis registry
-
Dec 15, 2008
First low-profile, pre-mounted stent approved specifically for use in renal arteries
-
Nov 24, 2008
A live webcast of the December 2, 2008 session will be available
-
Nov 10, 2008
New design provides more options for treating patients with complex lesions
-
Oct 29, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed passage of legislation to help active members of the U.S. armed forces and service...
-
Oct 27, 2008
Confirms clinical value and cost-effectiveness of spinal cord stimulation